IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL
Cramer, P., Demirkan, F., Fraser, G., Pristupa, A., Bartlett, N., Dilhuydy, M., Loscertales, J., Avigdor, A., Rule, S., Samoilova, O., Goy, A., Ganguly, S., Poggesi, I., Lavezzi, S.M., De Nicolao, G.,Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_95
Date:
June, 2017
File:
PDF, 244 KB
english, 2017